This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54(11), 1642-51
Citation
Stanley, Takara L; Falutz, Julian; Marsolais, Christian; Morin, Josée; Soulban, Graziella; Mamputu, Jean-Claude; Assaad, Hani; Turner, Ralph; Grinspoon, Steven K. (2012). Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54(11), 1642-51. https://doi.org/10.1093/cid/cis251